Suchergebnisse - (Subject:"Adalimumab")

PubPharm (80)

21

Tumor necrosis factor neutralization results in disseminated disease in acute and latent Mycobacterium tuberculosis infection with normal granuloma structure in a cynomolgus macaque model

enthalten in: Arthritis and rheumatism | 2010

von Lin, P. | Myers, A. | Smith, L. | +9

22

Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab : results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry

enthalten in: Arthritis and rheumatism | 2010

von Hetland, M. | Christensen, I. | Tarp, U. | +13

CommentIn: Arthritis Rheum. 2010 Sep;62(9):2826; author reply 2826-8. - PMID 20556822

23

Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies : does the risk change with the time since start of treatment?

enthalten in: Arthritis and rheumatism | 2009

von Askling, J. | van Vollenhoven, R. | Granath, F. | +12

CommentIn: Arthritis Rheum. 2009 Nov;60(11):3155-7. - PMID 19877064

24

Normalization of A2A and A3 adenosine receptor up-regulation in rheumatoid arthritis patients by treatment with anti-tumor necrosis factor alpha but not methotrexate

enthalten in: Arthritis and rheumatism | 2009

von Varani, K. | Massara, A. | Vincenzi, F. | +4

25

A 65-year-old man with longstanding seropositive rheumatoid arthritis and lower extremity ulceration

enthalten in: Arthritis and rheumatism | 2009

von Charabaty, S. | Shanmugam, V.

26

Anti-adalimumab antibodies in rheumatoid arthritis patients are associated with interleukin-10 gene polymorphisms

enthalten in: Arthritis and rheumatism | 2009

von Bartelds, G. | Wijbrandts, C. | Nurmohamed, M. | +6

27

Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy : The three-year prospective French Research Axed on Tolerance of Biotherapies registry

enthalten in: Arthritis and rheumatism | 2009

von Tubach, F. | Salmon, D. | Ravaud, P. | +114

ErratumIn: Arthritis Rheum. 2009 Aug;60(8):2540 Lorthololary, O [corrected to Lortholary, O]

28

Rheumatoid arthritis joint progression in sustained remission is determined by disease activity levels preceding the period of radiographic assessment

enthalten in: Arthritis and rheumatism | 2009

von Aletaha, D. | Funovits, J. | Breedveld, F. | +3

29

Comparison of drug retention rates and causes of drug discontinuation between anti-tumor necrosis factor agents in rheumatoid arthritis

enthalten in: Arthritis and rheumatism | 2009

von Du Pan, S. | Dehler, S. | Ciurea, A. | +4

30

Prior authorization for biologic disease-modifying antirheumatic drugs : a description of US Medicaid programs

enthalten in: Arthritis and rheumatism | 2008

von Fischer, M. | Polinski, J. | Servi, A. | +3